title: Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue.
abstract: Priapism is a debilitating disease for which there is at present no clinically accepted pharmacological intervention. It has been estimated that priapism lasting more than 24 h in patients is associated with a 44-90% rate of ED. In this investigation, we determined in two animal models of priapism (opiorphin-induced priapism in the rat and priapism in a mouse model of sickle cell disease) if there is evidence for an increase in markers of oxidative stress in corporal tissue. In both animal models, we demonstrate that priapism results in increased levels of lipid peroxidation, glutathione S-transferase activity and oxidatively damaged proteins in corporal tissue. Using western blot analysis, we demonstrated there is upregulation of the ubiquitination ligase proteins, Nedd-4 and Mdm-2, and the lysosomal autophage protein, LC3. The antiapoptotic protein, Bcl-2, was also upregulated. Overall, we demonstrate that priapism is associated with increased oxidative stress in corporal tissue and the activation of protein degradation pathways. As oxidative stress is known to mediate the development of ED resulting from several etiologies (for example, ED resulting from diabetes and aging), we suggest that damage to erectile tissue resulting from priapism might be prevented by treatments targeting oxidative stress.
authors.affiliation: Department of Urology, Institute of Smooth Muscle Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
authors.forename: N D
authors.initials: ND
authors.lastname: Kanika
authors.forename: A
authors.initials: A
authors.lastname: Melman
authors.forename: K P
authors.initials: KP
authors.lastname: Davies
mesh_terms: D000755:Anemia, Sickle Cell / Q000150:complications; D000818:Animals; D004195:Disease Models, Animal; D005982:Glutathione Transferase / Q000378:metabolism; D015227:Lipid Peroxidation; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009842:Oligopeptides / Q000008:administration & dosage; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000502:physiology*; D010413:Penis / Q000187:drug effects / Q000378:metabolism*; D011317:Priapism / Q000209:etiology / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D012471:Salivary Proteins and Peptides / Q000008:administration & dosage; D044767:Ubiquitin-Protein Ligases / Q000032:analysis; D054875:Ubiquitination
chemical_list: D009842:Oligopeptides; D011506:Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D012471:Salivary Proteins and Peptides; C517879:glutaminyl-arginyl-phenylalanyl-seryl-arginine; D044767:Ubiquitin-Protein Ligases; D005982:Glutathione Transferase